| Cvs Pharmacy #07172 | |
| 2001 Nicollet Ave, Minneapolis, Minnesota 55404 | |
| (612) 872-2656 |
| Name | Cvs Pharmacy #07172 |
|---|---|
| Organization Name | Grand St Paul Cvs Llc |
| Location | 2001 Nicollet Ave, Minneapolis, Minnesota 55404 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (612) 872-2656 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Atritech, Inc. today announced initial enrollment into its confirmatory study, PREVAIL, comparing the WATCHMAN® Left Atrial Appendage Closure Device to long term warfarin therapy in patients with atrial fibrillation. Doctors at Central Baptist Hospital in Lexington, Kentucky enrolled the first patient.
Writing in the U.S. Global Leadership Coalition's (USGLC) blog, Molly Lester, government relations associate at the USGLC, highlights a report released last week by the House Appropriations Committee Democrats that outlines the potential impact of budget sequestration on different agencies and issues.
A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population.
A binational team of researchers led by University of California, San Diego School of Medicine have discovered that active syphilis infections are significantly greater in female sex workers who inject drugs and share needles than those who don't. The findings suggest that injection drug use may play as big a role as risky sexual behavior in the transmission of syphilis. It may also exacerbate the spread of both HIV and syphilis, as syphilis is frequently a co-factor for HIV infection.
Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.
› Verified 6 days ago
| NPI Number | 1043497993 |
| Organization Name | GRAND ST PAUL CVS LLC |
| Doing Business As | CVS PHARMACY # 07172 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2001 Nicollet Avenue, Minneapolis, MN 55404 |
| Phone Number | 612-872-2656 |
News Archive
Atritech, Inc. today announced initial enrollment into its confirmatory study, PREVAIL, comparing the WATCHMAN® Left Atrial Appendage Closure Device to long term warfarin therapy in patients with atrial fibrillation. Doctors at Central Baptist Hospital in Lexington, Kentucky enrolled the first patient.
Writing in the U.S. Global Leadership Coalition's (USGLC) blog, Molly Lester, government relations associate at the USGLC, highlights a report released last week by the House Appropriations Committee Democrats that outlines the potential impact of budget sequestration on different agencies and issues.
A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population.
A binational team of researchers led by University of California, San Diego School of Medicine have discovered that active syphilis infections are significantly greater in female sex workers who inject drugs and share needles than those who don't. The findings suggest that injection drug use may play as big a role as risky sexual behavior in the transmission of syphilis. It may also exacerbate the spread of both HIV and syphilis, as syphilis is frequently a co-factor for HIV infection.
Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.
› Verified 6 days ago
News Archive
Atritech, Inc. today announced initial enrollment into its confirmatory study, PREVAIL, comparing the WATCHMAN® Left Atrial Appendage Closure Device to long term warfarin therapy in patients with atrial fibrillation. Doctors at Central Baptist Hospital in Lexington, Kentucky enrolled the first patient.
Writing in the U.S. Global Leadership Coalition's (USGLC) blog, Molly Lester, government relations associate at the USGLC, highlights a report released last week by the House Appropriations Committee Democrats that outlines the potential impact of budget sequestration on different agencies and issues.
A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population.
A binational team of researchers led by University of California, San Diego School of Medicine have discovered that active syphilis infections are significantly greater in female sex workers who inject drugs and share needles than those who don't. The findings suggest that injection drug use may play as big a role as risky sexual behavior in the transmission of syphilis. It may also exacerbate the spread of both HIV and syphilis, as syphilis is frequently a co-factor for HIV infection.
Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.
› Verified 6 days ago
Mesa Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2603 Bloomington Ave, Minneapolis, Minnesota 55407 Phone: (612) 501-5009 | |
Alina Health System Type: Community/Retail Pharmacy Location: 913 E 28th Street, Minneapolis, Minnesota 55407 Phone: (612) 863-5370 | |
Allina Health System Type: Clinic Pharmacy Location: 920 E 28th St, Minneapolis, Minnesota 55407 Phone: (612) 775-3100 | |
Cvs Pharmacy #07172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 Nicollet Ave, Minneapolis, Minnesota 55404 Phone: (612) 872-2656 | |
Cvs Pharmacy #05996 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3655 Central Ave Ne, Minneapolis, Minnesota 55418 Phone: (612) 789-2460 |